Cosmos Health Inc. - SIC # 7352 - MEDICAL EQUIPMENT RENTAL AND LEASING

Ticker Exchange SIC # Website Latest Ticker
COSM Nasdaq 7352 www.cosmoshealthinc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cosmos Health Inc.

Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases - Jul 6th, 2026 12:30 pm
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases - Jul 2nd, 2026 12:10 pm
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace - Jul 1st, 2026 9:05 am
Why Did SOC, HTZ, COSM Stocks Tumble To 52-Week Lows? - Jun 30th, 2026 11:06 pm
Cosmos Health Authorizes Up to $5 Million Share Repurchase Program - Jun 30th, 2026 9:55 am
This Nano Cap Company Tapped A Key Distribution Partner In Qatar – CEO Calls It ‘High-Impact Partnership’ - Jun 26th, 2026 11:32 am
Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units - Jun 26th, 2026 10:30 am
Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada - Jun 25th, 2026 1:31 pm
Cosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin - Jun 24th, 2026 1:37 pm
Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency - Jun 23rd, 2026 1:35 pm
Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit - Jun 22nd, 2026 8:30 am
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity - Jun 18th, 2026 1:34 pm
Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States - Jun 17th, 2026 1:35 pm
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products - Jun 17th, 2026 7:27 am
Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit - Jun 15th, 2026 7:00 am
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines - Jun 12th, 2026 1:33 pm
Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit - Jun 12th, 2026 7:29 am
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio - Jun 11th, 2026 1:31 pm
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance - Jun 11th, 2026 7:35 am
Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries - Jun 10th, 2026 1:32 pm